Abstract
Two epimeric metabolites of Larotaxel were synthesized in eight steps from 10-DAB III as a commercial material and their structures were characterized using NMR and MS spectral data. The cytotoxicity of two metabolites was performed on breast cancer cell lines MCF-7, MX-1 and MDA-MB-231. It is remarkable that both of these two desired taxanes showed great potent cytotoxic effect.
Keywords: Larotaxel, taxanes, synthesis, MCF-7, cytotoxicity, breast cancer.
Graphical Abstract
Anti-Cancer Agents in Medicinal Chemistry
Title:Synthesis and Cytotoxicity of Two Active Metabolites of Larotaxel
Volume: 16 Issue: 7
Author(s): Jianwei Li, Anping Li, Minghua Li, Yufeng Qiao and Hui Zhang
Affiliation:
Keywords: Larotaxel, taxanes, synthesis, MCF-7, cytotoxicity, breast cancer.
Abstract: Two epimeric metabolites of Larotaxel were synthesized in eight steps from 10-DAB III as a commercial material and their structures were characterized using NMR and MS spectral data. The cytotoxicity of two metabolites was performed on breast cancer cell lines MCF-7, MX-1 and MDA-MB-231. It is remarkable that both of these two desired taxanes showed great potent cytotoxic effect.
Export Options
About this article
Cite this article as:
Li Jianwei, Li Anping, Li Minghua, Qiao Yufeng and Zhang Hui, Synthesis and Cytotoxicity of Two Active Metabolites of Larotaxel, Anti-Cancer Agents in Medicinal Chemistry 2016; 16 (7) . https://dx.doi.org/10.2174/1871520616666160201151344
DOI https://dx.doi.org/10.2174/1871520616666160201151344 |
Print ISSN 1871-5206 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5992 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Post-Stroke Immunodepression and Infection: An Emerging Concept
Infectious Disorders - Drug Targets Patent Annotations
Recent Patents on CNS Drug Discovery (Discontinued) DNA Microarray-Based Gene Expression Profiling in Cancer: Aiding Cancer Diagnosis, Assessing Prognosis and Predicting Response to Therapy
Current Pharmacogenomics Solubility Enhancement and Delivery Systems of Curcumin a Herbal Medicine: A Review
Current Drug Delivery Suppression of Glial HO-1 Activitiy as a Potential Neurotherapeutic Intervention in AD
Current Alzheimer Research Psychosocial Factors and Central Sensitivity Syndromes
Current Rheumatology Reviews Staging of Breast Cancer with 18F-FDG PET and PET/CT
Current Medical Imaging Gene Expression Assay in the Management of Early Breast Cancer
Current Medicinal Chemistry Emerging Indications for Statins: A Pluripotent Family of Agents with Several Potential Applications
Current Pharmaceutical Design Editorial [Hot Topic: Targeted Therapy, Targeted Dosing and Targeted Delivery in Oncology: Where Do We Stand?]
Current Topics in Medicinal Chemistry Neurokinin-1 Receptor Antagonist Can Prevent the Delayed Phase in Patients: A Single Center Retrospect Study
Anti-Cancer Agents in Medicinal Chemistry Lectin Microarrays: A Powerful Tool for Glycan-Based Biomarker Discovery
Combinatorial Chemistry & High Throughput Screening The Role of Ribavirin in the Combination Therapy of Hepatitis C Virus Infection
Current Pharmaceutical Design Disposition of Pharmacologically Active Dietary Isoflavones in Biological Systems
Current Drug Metabolism Recent Trends in Development of Fermented Milks
Current Nutrition & Food Science Publishing Orthology and Diseases Information in the Linked Open Data Cloud
Current Bioinformatics Meet Our Editorial Board Member
Current Chemical Biology Therapeutic Rationale for mTOR Inhibition in Advanced Renal Cell Carcinoma
Current Clinical Pharmacology “Letting the Air In” Can Set the Stage for Tumor Recurrences
Current Cancer Therapy Reviews An Efficient Four-Step Approach Toward Fused Triazino[1,6-a] Quinazolines
Combinatorial Chemistry & High Throughput Screening